Increased tumor incidences in Brg1IEC-AKO mice were associated with the persistent inflammation, as reflected by increased IL-6, IL-1β, TNFα and CCL2 productions in the 5 months of AOM-treated Brg1IEC-AKO mice (Fig. 3b). This evidence concerns the gene CCL2 and neoplasm.